MARKET

RXRX

RXRX

RECURSION PHARMACEUTICALS, INC.
NASDAQ

Real-time Quotes | Nasdaq Last Sale

30.72
-2.49
-7.50%
After Hours: 30.60 -0.12 -0.39% 17:16 07/27 EDT
OPEN
32.99
PREV CLOSE
33.21
HIGH
33.00
LOW
29.20
VOLUME
518.82K
TURNOVER
--
52 WEEK HIGH
42.81
52 WEEK LOW
19.68
MARKET CAP
5.17B
P/E (TTM)
-5.1270
1D
5D
1M
3M
1Y
5Y
What You Need To Know About Recursion Pharmaceuticals, Inc.'s (NASDAQ:RXRX) Investor Composition
The big shareholder groups in Recursion Pharmaceuticals, Inc. ( NASDAQ:RXRX ) have power over the company. Generally...
Simply Wall St. · 07/16 10:20
Prometheus Bio and Recursion Pharma on track to post record one-day losses
Mir Basar Suhaib/iStock via Getty Images Recently IPO’ed biotech firms Prometheus Biosciences ([[RXDX]] -21.5%) and Recursion Pharmaceuticals ([[RXRX]] -19.2%) are on course to record their biggest one-day losses since their
Seekingalpha · 07/14 19:43
The Daily Biotech Pulse: ScPharma's Positive Data, Lilly Goes Shopping, LeMaitre Pre-Announces Q2 Revenues
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 13)
Benzinga · 07/14 11:48
Stocks That Hit 52-Week Highs On Tuesday
    Before 10 a.m. ET on Tuesday, 128 companies hit new 52-week highs.
Benzinga · 07/13 15:42
The Daily Biotech Pulse: Equillium Issues Positive Regulatory Update, Biogen In-Licenses Multiple Sclerosis Drug, Aridis Releases COVID-19 Antibody Cocktail Data
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 12)
Benzinga · 07/13 12:05
Recursion Reports Formation Of A Therapeutics Advisory Board
 Recursion (NASDAQ:RXRX), a clinical-stage biotechnology company decoding biology by integrating technological innovations across biology, chemistry, automation, machine learning and engineering, today announced its
Benzinga · 07/13 11:59
Recursion forms Therapeutics Advisory Board
Recursion (RXRX) announces the formation of a Therapeutics Advisory Board ((TAB)), chaired by Joseph Miletich.Most recently, Miletich was Merck Research Laboratories' senior vice president of research sciences and is currently senior scientific advisor to
Seekingalpha · 07/13 11:59
Recursion Announces Therapeutics Advisory Board, Chaired by Joseph Miletich, MD, PhD
Recursion (NASDAQ: RXRX), a clinical-stage biotechnology company decoding biology by integrating technological innovations across biology, chemistry, automation, machine learning and engineering, today announced its formation of a Therapeutics Advisory Boa...
PR Newswire · 07/13 11:55
More
Forecast
Actual (USD)
Estimate (USD)
Income StatementMore
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
Operating (USD)
YoY (%)
Learn about the latest financial forecast of RXRX. Analyze the recent business situations of RECURSION PHARMACEUTICALS, INC. through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 5 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average RXRX stock price target is 33.50 with a high estimate of 36.00 and a low estimate of 31.00.
EPS
Institutional Holdings
Institutions: 1
Institutional Holdings: 7.02K
% Owned: 0.00%
Shares Outstanding: 168.32M
TypeInstitutionsShares
Increased
0
0
New
1
7.02K
Decreased
0
0
Sold Out
0
0
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Biotechnology & Medical Research
-1.04%
Pharmaceuticals & Medical Research
-0.18%
Key Executives
Non-Executive Chairman/Independent Director
R. Martin Chavez
President/Chief Operating Officer
Tina Larson
Chief Executive Officer/Director
Christopher Gibson
Chief Financial Officer/Primary Contact
Michael Secora
Chief Human Resource Officer
Heather Kirkby
Chief Technology Officer
Benjamin Mabey
Chief Scientific Officer
Sharathchandra Hegde
General Counsel
Louisa Daniels
Other
Ramona Doyle
Other
Mason Victors
Other
Shafique Virani
Independent Director
Zachary Bogue
Independent Director
Blake Borgeson
Independent Director
Terry - Ann Burrell
Independent Director
Zavain Dar
Independent Director
Robert Hershberg
Independent Director
Dean Li
No Data
  • All
  • Financials
  • Insiders
More
About RXRX
Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company. The Company uses Recursion Operating System (Recursion OS), a multi-layer system for generating, analyzing and deriving insights from biological and chemical datasets. It consists of three parts: Infrastructure Layer, The Recursion Data Universe and The Recursion Map. Its programs include REC-4881, REC-3599, REC-2282, REC-994, lead molecules for the treatment of C. difficile Colitis, lead molecules for the treatment of Neuroinflammation, lead molecules for the treatment of Batten Disease and lead molecules for the treatment of CMT2A.

Webull offers kinds of Recursion Pharmaceuticals Inc stock information, including NASDAQ:RXRX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, RXRX stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading RXRX stock methods without spending real money on the virtual paper trading platform.